Developments in advanced prostate cancer in 2016

Martin J P Hennig; Nils Gilbert; Axel S. Merseburger

Developments in advanced prostate cancer in 2016

Martin J P Hennig, Nils Gilbert, Axel S. Merseburger^*

^*Korrespondierende/r Autor/-in für diese Arbeit

Klinik für Urologie

Abstract

As we have experienced before, the diagnostic and therapeutic landscape is transient and rapidly evolving, especially in regards to advanced prostate cancer (PC). As practical clinicians and care providers we must not just stay in touch with the latest developments in the field but anticipate the needs of our clientele and patients. This editorial will provide a brief summary of the latest ground-breaking developments with clinical impact in the field of prostate cancer.

Originalsprache	Englisch
Zeitschrift	European Oncology and Haematology
Jahrgang	12
Ausgabenummer	1
Seiten (von - bis)	17-18
Seitenumfang	2
ISSN	2045-5275
Publikationsstatus	Veröffentlicht - 01.06.2016

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Weitere Links

Link to publication in Scopus

Zitieren

@article{eab9b93d50da490da1aa873d36dc9525,

title = "Developments in advanced prostate cancer in 2016",

abstract = "As we have experienced before, the diagnostic and therapeutic landscape is transient and rapidly evolving, especially in regards to advanced prostate cancer (PC). As practical clinicians and care providers we must not just stay in touch with the latest developments in the field but anticipate the needs of our clientele and patients. This editorial will provide a brief summary of the latest ground-breaking developments with clinical impact in the field of prostate cancer.",

author = "Hennig, \{Martin J P\} and Nils Gilbert and Merseburger, \{Axel S.\}",

year = "2016",

month = jun,

day = "1",

language = "English",

volume = "12",

pages = "17--18",

journal = "European Oncology and Haematology",

issn = "2045-5275",

publisher = "Touch Briefings",

number = "1",

}

TY - JOUR

T1 - Developments in advanced prostate cancer in 2016

AU - Hennig, Martin J P

AU - Gilbert, Nils

AU - Merseburger, Axel S.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - As we have experienced before, the diagnostic and therapeutic landscape is transient and rapidly evolving, especially in regards to advanced prostate cancer (PC). As practical clinicians and care providers we must not just stay in touch with the latest developments in the field but anticipate the needs of our clientele and patients. This editorial will provide a brief summary of the latest ground-breaking developments with clinical impact in the field of prostate cancer.

AB - As we have experienced before, the diagnostic and therapeutic landscape is transient and rapidly evolving, especially in regards to advanced prostate cancer (PC). As practical clinicians and care providers we must not just stay in touch with the latest developments in the field but anticipate the needs of our clientele and patients. This editorial will provide a brief summary of the latest ground-breaking developments with clinical impact in the field of prostate cancer.

UR - https://www.scopus.com/pages/publications/84970973859

M3 - Editorial

AN - SCOPUS:84970973859

SN - 2045-5275

VL - 12

SP - 17

EP - 18

JO - European Oncology and Haematology

JF - European Oncology and Haematology

IS - 1

ER -

Developments in advanced prostate cancer in 2016

Abstract

UN SDGs

Weitere Links

Fingerprint

Zitieren